Association between serum vitamin D concentration and liver fibrosis in diabetes mellitus patients: a cross-sectional study from the NHANES database
- PMID: 38831202
- DOI: 10.1007/s00592-024-02292-3
Association between serum vitamin D concentration and liver fibrosis in diabetes mellitus patients: a cross-sectional study from the NHANES database
Abstract
Aim: Liver fibrosis (LF) is a common complication of diabetes mellitus (DM). Studies have found that vitamin D (VD), as a modifiable factor has been reported to be associated with LF. The relationship between serum VD concentration and LF in DM patients has rarely been reported. The aim of this study was to assess the association between serum VD concentration and LF in DM patients.
Methods: In this cross-sectional study, data of DM patients aged ≥ 45 years were extracted from the National Health and Nutrition Examination Survey (NHANES 2017-2018). Serum VD concentration was measured by high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). Vibration controlled transient elastography (VCTE) was used to measure liver stiffness. Covariates included sociodemographic information, lifestyles, laboratory data, diseases history were extracted from the database. The weighted univariable and multivariable logistic regression models were utilized to explore the association between serum VD concentration and LF in DM patients, and were described as odds ratio (ORs) and 95% confidence intervals (CIs). Subgroup analyses based on BMI, liver steatosis, hypertension and dyslipidemia were further assessed the association.
Results: A total of 799 patients were included, of which 188 (23.53%) had LF. Higher serum VD concentration was associated with the lower odds of LF (OR = 0.33, 95% CI 0.19-0.59) and advanced LF (OR = 0.31, 95% CI 0.17-0.55) in DM patients after adjustment for race, liver steatosis, BMI, smoking, drinking, AST, ALT and physical activity, especially in patients with liver steatosis (OR = 0.28, 95% CI 0.13-0.59) and dyslipidemia (OR = 0.31, 95% CI 0.14-0.66), respectively.
Conclusions: High serum VD concentration may have a potential benefit for maintain the liver health in DM patients.
Keywords: Diabetes mellitus; Liver fibrosis; NHANES database; Serum vitamin D.
© 2024. Springer-Verlag Italia S.r.l., part of Springer Nature.
Similar articles
-
Association between dietary magnesium intake and liver fibrosis among type 2 diabetes mellitus patients: a cross-sectional study from the NHANES database.Magnes Res. 2024 Jul 1;37(1):33-44. doi: 10.1684/mrh.2024.0527. Magnes Res. 2024. PMID: 39077822
-
Serum klotho concentration, vitamin D concentration and cardiovascular diseases risk: Evidence from the NHANES database 2007-2016.Nutr Metab Cardiovasc Dis. 2025 Jun;35(6):103905. doi: 10.1016/j.numecd.2025.103905. Epub 2025 Feb 5. Nutr Metab Cardiovasc Dis. 2025. PMID: 40199712
-
Relevance of vitamin D on NAFLD and liver fibrosis detected by vibration controlled transient elastography in US adults: a cross-sectional analysis of NHANES 2017-2018.Ann Med. 2023 Dec;55(1):2209335. doi: 10.1080/07853890.2023.2209335. Ann Med. 2023. PMID: 37155562 Free PMC article.
-
Magnesium status, serum vitamin D concentration and mortality among congestive heart failure patients: a cohort study from NHANES 2007-2018.Magnes Res. 2024 Nov 1;37(2):61-75. doi: 10.1684/mrh.2024.0528. Magnes Res. 2024. PMID: 39601307
-
Vitamin B6 status, type 2 diabetes mellitus, and periodontitis: evidence from the NHANES database 2009-2010.BMC Oral Health. 2025 Feb 24;25(1):299. doi: 10.1186/s12903-025-05597-z. BMC Oral Health. 2025. PMID: 39994649 Free PMC article.
References
-
- The Prevention of Diabetes Mellitus (2021). Jama 325(2):190. https://doi.org/10.1001/jama.2020.17738
-
- Zheng Y, Ley SH, Hu FB (2018) Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14(2):88–98. https://doi.org/10.1038/nrendo.2017.151 - DOI - PubMed
-
- Demir S, Nawroth PP, Herzig S, Ekim Üstünel B (2021) Emerging targets in type 2 diabetes and diabetic complications. Adv Sci (Weinh) 8(18):e2100275. https://doi.org/10.1002/advs.202100275 - DOI - PubMed
-
- Su RC, Lad A, Breidenbach JD et al (2019) Hyperglycemia induces key genetic and phenotypic changes in human liver epithelial HepG2 cells which parallel the Leprdb/J mouse model of non-alcoholic fatty liver disease (NAFLD). PLoS ONE 14(12):e0225604. https://doi.org/10.1371/journal.pone.0225604 - DOI - PubMed - PMC
-
- Dai Y, Hao P, Sun Z et al (2021) Liver knockout YAP gene improved insulin resistance-induced hepatic fibrosis. J Endocrinol 249(2):149–161. https://doi.org/10.1530/joe-20-0561 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical